Petr Vaculík, country manager of PSI CRO, a privately owned Swiss clinical research organization (CRO), describes how the number of clinical trials is decreasing in the Czech Republic, although many continue to capitalize on the country’s universal healthcare system. Vaculík also shares his views on how to retain a strong workforce, how key stakeholders are coming together to help shape the research landscape for the better.
We are highly competitive in terms of patient recruitment. We have some of the highest numbers of patients in clinical trials per total number of patients in the CEE Region
